{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/c3fd12d1-925e-5452-ae69-4fa9c6562609/66f2171cdf5b4a5829e49288?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"the call: Tuesday 24 September","description":"<p>Submit your stock picks here: <a href=\"ausbiz.co/callpicks\" rel=\"noopener noreferrer\" target=\"_blank\">ausbiz.co/callpicks</a></p><p><br></p><p>Ben Clark from TMS Capital and Rudi Filapek-Vandyck from FNArena go in-depth and stock specific on ‘the call.’</p><p>Dicker Data (DDR)&nbsp;</p><p>Appen (APX)</p><p>Gentrack (GTK)&nbsp;</p><p>Australian Clinical Labs (ACL)&nbsp;</p><p>Integral Diagnostics (IDX)&nbsp;</p><p>Centuria Capital (CNI)&nbsp;</p><p>IPH (IPH)&nbsp;</p><p>Helia Group (HLI)&nbsp;</p><p>Origin Energy (ORG)&nbsp;</p><p>New Hope Corporation (NHC)</p><p><br></p><p>Stock of the day: Cettire (CTT) to listen go to <a href=\"https://ausbiz.co/STOD\" rel=\"noopener noreferrer\" target=\"_blank\">https://ausbiz.co/STOD</a></p><p><br></p><p>Get your stock pick to the front of the queue by becoming an ausbiz contributor: <a href=\"https://ausbiz.co/contributors\" rel=\"noopener noreferrer\" target=\"_blank\">https://ausbiz.co/contributors</a></p><p><br></p><p>And we'd love it if you could leave us a review below!</p>","author_name":"ausbiz"}